Health Care/Hospital
Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target
GAITHERSBURG, Md., Nov. 14, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...
2023-11-14 21:30
1342
Geekplus projects win in three categories in the 2023 Supply Chain Excellence Awards
* Geekplus, beside partners Asda Logistics, AMH Material Handling and Dr. Max Romania, has been recognized as the best project in three different ACEA award categories: The Unipart Logistics Digital Transformation Award, The Healthcare & Pharmaceutical Supply Chain Excellence Award, and the Vi...
2023-11-14 21:06
1419
AXA Introduces "Better She"
First Comprehensive Menopausal Health Management Programme[1] in HK Supporting Women in Hong Kong to Reclaim Their Health and Be On Track for 100% Selves HONG KONG, Nov. 14, 2023 /PRNewswire/ -- AXA Hong Kong and Macau is proud to introduce the"Better She" Programme ("Better She"), the first meno...
2023-11-14 12:12
1919
George Clinical Partners with Medidata to Unlock Operational Efficiency in Clinical Trials
Medidata's Rave Grants Manager will be implemented across 50 multinational studies and multiple therapeutic areas SYDNEY, Nov. 14, 2023 /PRNewswire/ -- Medidata, a Dassault Systèmes company, announced today that George Clinical, a leading global clinical research organization, is leveraging Med...
2023-11-14 10:48
1723
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023
Direct evidence that BRII-179-induced functional antibody responses can contribute to increased and sustained HBsAg loss rate New insight in utilizing BRII-179 to enriching patients with intrinsic humoral immune responses for higher HBsAg loss or HBV functional cure rates New data support ...
2023-11-14 06:40
1914
Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®
MELBOURNE, Australia, Nov. 14, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a conditional Term Sheet to acquire QSAM Biosciences, Inc. (QSAM) and its lead asset, CycloSam® (Samarium-153-DOTMP). QSAM is a United States (U.S.) based...
2023-11-14 06:33
1442
Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety
PHILADELPHIA, Nov. 14, 2023 /PRNewswire/ -- Rx-360 is pleased to announce that the consortium membership led by key members of the Supplier Quality Working Group have released two new papers this week to help drive best practices in pharmaceutical supply chain integrity and patient safety. The t...
2023-11-14 03:00
1699
SCG Cell Therapy Announces Late-Breaking Clinical Data at AASLD Showing SCG101 Improved Tumor Reponses and Achieved Sustained Antiviral Activates in Patients with Advanced HBV-related Hepatocellular Carcinoma
SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced late-breaking clinical data from its first-in-class autologous hepatitis B virus ...
2023-11-14 02:00
2818
More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds
Global research from the International Diabetes Federation reveals that 72% of people living with diabetes only received their diagnosis because they had at least one of the related complications – such as loss of vision, nerve damage or heart disease. BRUSSELS, Nov. 14, 2023 /PRNewswire/ -- Sev...
2023-11-14 00:36
1644
Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries
Program aims to address key barriers to genomic sequencing in-country SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to p...
2023-11-13 22:15
1719
Agora Announces RTE Telehealth, A Webinar Exploring the Impact of AI and AR/VR in Virtual Healthcare
The dual session will explore how emerging technologies can improve patient interaction and healthcare delivery in telehealth SANTA CLARA, Calif., Nov. 13, 2023 /PRNewswire/ -- Agora, Inc. (NASDAQ: API), a pioneer and leading platform for real-time engagement APIs, has announced its RTE Teleheal...
2023-11-13 22:00
1507
LIFE FITNESS ANNOUNCES SYMBIO, A FIRST-OF-ITS-KIND PREMIUM CARDIO LINE, REIMAGINING THE FITNESS EXPERIENCE
ROSEMONT, Ill., Nov. 13, 2023 /PRNewswire/ -- Life Fitness, the global leader
in commercial fitness equipment, today announced the launch of its cardio line,
Symbio™, an immersive, four-machine collection.
2023-11-13 22:00
2304
DFS GROUP Collaborates with Galaxy Macau to Spread Positive Energy with Wellness
Discover " The Best Of You, Now "Hong Kong HONG KONG, Nov. 13, 2023 /PRNewswire/ -- This autumn and winter, DFS Group, the world's leading luxury travel retail company, is partnering with Galaxy Macau™ Integrated Resort to launch a wellness-themed event at DFS's first "green" store in their net...
2023-11-13 21:15
1861
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests
GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing cancer early detection tests, announced today that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectio...
2023-11-13 21:00
1672
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
Bylvay (odevixibat) is the first and only oral treatment available in Canada
for the treatment of pruritus due to this rare genetic condition
ZUG, Switzerland and PARIS, Nov. 13, 2023 /PRNewswire/ -- Today, Ipsen
2023-11-13 20:20
1304
TB Alliance Applauds Macleods' Launch of a Key Component of WHO-Recommended Drug-Resistant TB Treatment Regimen
Macleods becomes second pharmaceutical manufacturer to bring pretomanid supply to market and first since the World Health Organization issued updated DR-TB treatment guidelines NEW YORK, Nov. 13, 2023 /PRNewswire/ -- Indian pharmaceutical company Macleods has become the second manufacturer to la...
2023-11-13 18:31
1350
The FHH Forum 2023, which was held yesterday in Geneva, on the theme "Horology Futurology", proved to be a crossroads of avant-garde ideas and constructive debate, guided by exchanges and in-depth discussions with renowned experts
GENEVA, Nov. 13, 2023 /PRNewswire/ -- The Fondation Haute Horlogerie successfully hosted the 11th edition of the FHH Forum at the Maison de la Paix yesterday inGeneva. Under the evocative theme "Horology Futurology", the event saw the participation of around 200 people. The day echoed the mission...
2023-11-13 17:30
2291
Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) andParis-based Mauna Kea Technologies (Euronext Growth: ALMKT,Mauna Kea), today announce an expansion of the IRiS (Imaging and Robotics in Surgery) Alliance[1] through a stra...
2023-11-13 16:27
1492
Fundiin partners with Pharmacity to launch BNPL at a thousand drugstores in Vietnam
Fundiin and Pharmacity have forged the first-ever Buy Now Pay Later (BNPL) partnership in the pharmacy retail sector, with Fundiin being the most popular BNPL provider inVietnam and Pharmacity emerging as the regional leading drugstore chain. HO CHI MINH CITY, Vietnam, Nov. 13, 2023 /PRNewswire/...
2023-11-13 14:58
2514
USgHIFUa: a listed Operation at public hospitals
and available at Cornwall Medical in the private sector HONG KONG, Nov. 13, 2023 /PRNewswire/ -- "High intensity focused ultrasound ablation of lesion of uterus using ultrasound guidance" has been included as an "Operation" categorized under "INTERMEDIATEII" on the "List of Private Services"[i] ...
2023-11-13 09:00
1283
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 294 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 285 media titles]
2024-11-15 15:25
Most Read
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
2024-11-13 09:00
6529
Sobot Introduces its All-in-One Solution at GITEX Global 2024
2024-11-12 11:00
5924
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5699